Berry Street Buys MyScribe AI, Hires Founder as Lead Engineer
Berry Street acquires MyScribe's AI technology and IP, hiring founder Dr. Wasif Bokhari as Lead AI Engineer to build clinician-facing tools across its 2,000-clinician nutrition therapy network.
By Olivia Hart
3 min read

What's News
- Berry Street acquired MyScribe's technology and IP; MyScribe's standalone service is discontinued.
- MyScribe founder Dr. Wasif Bokhari joined Berry Street as Lead AI Engineer.
- Berry Street's clinician network exceeds 2,000 providers serving patients in all 50 states.
- The platform supports care for weight, diabetes, heart health, kidney disease and 30+ additional conditions.
- Deal terms and purchase price were not disclosed.
Berry Street has acquired the technology and intellectual property of MyScribe, an AI clinical assistant for healthcare professionals, and brought MyScribe founder Dr. Wasif Bokhari in as Lead AI Engineer. The deal folds a standalone product into a metabolic health company whose network includes more than 2,000 clinicians. MyScribe's own service is being discontinued as Bokhari shifts to building AI inside Berry Street. In plain terms, this is an acqui-hire with IP attached, not a product merger.
Berry Street provides personalized nutrition therapy through clinicians and AI-powered technology. Its platform treats patients managing weight, diabetes, heart health, kidney disease, maternal health and more than 30 additional conditions. Patients get individual clinician care and can use the Berry Street app between appointments for AI-powered guidance, meal tracking and health information. The platform also syncs data from wearable devices and laboratory results. The takeaway: the company already has a live AI surface for patients, and the acquisition adds engineering depth behind it.
What does the deal cover?
The transaction transfers MyScribe's technology and intellectual property to Berry Street. It also moves its founder. Bokhari built MyScribe to help dietitians and clinicians use AI in daily work. Before founding the company, he was among the first AI engineering hires at Hims & Hers, served as founding AI engineer at ShopMy, and worked at Intel. At Berry Street, he will develop AI capabilities for both patients and healthcare professionals, plus models tied to the company's growth and operating processes. The company argues his record of building clinical tools that fit existing care workflows justifies the hire; the proof will be what ships, not the resume.
What are the leaders saying?
Berry Street Co-CEO Noah Kotlove framed the deal as validation of a pairing strategy. "Our bet is AI and clinicians working together. Wasif had already built AI that clinicians used every day. Since joining us, he's brought that same instinct to how our patients get care and how our clinicians deliver it," Kotlove said. Note what the quote does not say: no revenue figures, no user counts for MyScribe, no purchase price. The deal terms remain undisclosed.
Bokhari cast the move as scale plus payment model. "I started MyScribe to make AI genuinely useful for dietitians and clinicians. At Berry Street I get to do that work at a much bigger scale, for patients whose care is covered by their insurance," he said. That insurance angle is the operational difference. Berry Street works with health plans, health systems and care management organizations to make nutrition therapy available across all 50 states. The company says insurance covers care in many cases, letting eligible patients receive services with limited or no out-of-pocket cost — a claim that will depend on individual plans, and Berry Street does not quantify coverage rates.
Why does the AI-plus-clinician model matter commercially?
Berry Street's stated strategy uses AI alongside clinicians rather than replacing human care. The company believes AI can keep patients engaged with nutrition programs between appointments and help clinicians manage workloads. Potential applications include documentation assistance, patient communication, personalized guidance and administrative processes. Each of those targets a known cost center in clinical practice, though the source names no pilot results or adoption metrics. Kotlove said Bokhari had already demonstrated an ability to develop technology clinicians used regularly, and the company intends to apply that expertise across its larger clinical network.
The acquisition strengthens Berry Street's position as a technology-enabled nutrition therapy provider, according to the company's own framing. The test ahead is whether Bokhari's tools reach meaningful adoption across a 2,000-clinician network — and whether the engagement gains the company expects translate into measurable outcomes.
Source: pulse2.com
More from Olivia Hart
Show full bio
Staff writer covering people, launches and day-to-day practice in entrepreneurship, startups and venture funding at Business Bearings.
2,205 articles